University at Buffalo - The State University of New York
Skip to Content
PubMed Central, Figure 7: PLoS One. 2013; 8(8): e69678. Published online 2013 Aug 2. doi:  10.1371/journal.pone.0069678
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PMC full text:

Figure 7

An external file that holds a picture, illustration, etc.
Object name is pone.0069678.g007.jpg
I.n. immunization of RiVax with LT-IIb(T13I) enhances protective immunity to ricin.

Mice were immunized intranasally on days 0, 10, 20, and 34 with 0.5 µg of RiVax in the presence or absence of 1.0 µg of LT-IIb or LT-IIb(T13I) and challenged 14 days after the final immunization with 10 LD50 of ricin. (A) Survival of mice after i.p. challenge with ricin. Data were compared by the Logrank test. (B) Blood glucose levels of immunized mice during ricin challenge. Data are presented as the arithmetic mean with error bars denoting one S.E.M. (n = 4 or 5) Key: **, p<0.01 compared to RiVax; †, p<0.01 compared to 0 h. Data were compared using an unpaired Students t-test.

Images in this article

  • Figure 1
  • Figure 2
  • Figure 3
  • Figure 4
  • Figure 5
  • Figure 6
  • Figure 7
Click on the image to see a larger version.